|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-2-2
|
|
pubmed:abstractText |
High-affinity somatostatin receptors (SRs) have been characterized in neuroblastomas and may be used as target structures for in vivo detection of SR.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
688-91
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11107147-3-Iodobenzylguanidine,
pubmed-meshheading:11107147-Child, Preschool,
pubmed-meshheading:11107147-Disease-Free Survival,
pubmed-meshheading:11107147-Female,
pubmed-meshheading:11107147-Follow-Up Studies,
pubmed-meshheading:11107147-Humans,
pubmed-meshheading:11107147-Indium Radioisotopes,
pubmed-meshheading:11107147-Infant,
pubmed-meshheading:11107147-Infant, Newborn,
pubmed-meshheading:11107147-Male,
pubmed-meshheading:11107147-Neuroblastoma,
pubmed-meshheading:11107147-Prognosis,
pubmed-meshheading:11107147-Radiopharmaceuticals,
pubmed-meshheading:11107147-Somatostatin,
pubmed-meshheading:11107147-Survival Rate
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information.
|
|
pubmed:affiliation |
Oncology/Hematology/Immunology, Olgahospital, Childhood and Adolescent Health, Stuttgart, Germany. fhs@nbs.s.shuttle.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
